NICE expands Bayer's Stivarga prospects with move from CDF

12th October 2017 Uncategorised 0

Since the National Institute for Health and Care Excellence took the reins of England’s Cancer Drugs Fund last year, several drugmakers have seen their oncology meds get the boot. Not Bayer.

More: NICE expands Bayer's Stivarga prospects with move from CDF
Source: fierce